Research Article

DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy

Figure 4

Disease-free survival analysis of 60 locally advanced rectal cancer patients according to results of a multiple genetic biomarkers panel. The median survival rate was 47.01 months in 60 locally advanced rectal cancer patients with positive results, while the median survival rate was only 22.16 months in patients with negative results ( ).
931028.fig.004